David Rescott
Stock Analyst at Baird
(3.85)
# 668
Out of 5,122 analysts
78
Total ratings
62.3%
Success rate
8.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Downgrades: Neutral | $345 → $374 | $356.00 | +5.06% | 32 | Jan 16, 2026 | |
| SIBN SI-BONE | Maintains: Buy | $21 → $23 | $16.26 | +41.45% | 8 | Dec 18, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $88 → $87 | $82.10 | +5.97% | 7 | Dec 16, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $87 → $99 | $64.86 | +52.64% | 2 | Dec 15, 2025 | |
| MDT Medtronic | Maintains: Neutral | $103 → $109 | $103.18 | +5.64% | 8 | Nov 19, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $63 → $70 | $65.93 | +6.17% | 6 | Nov 13, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $123 → $128 | $91.62 | +39.71% | 9 | Oct 1, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $80.49 | +36.66% | 3 | Apr 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $478.88 | +20.07% | 3 | Apr 23, 2025 |
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345 → $374
Current: $356.00
Upside: +5.06%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21 → $23
Current: $16.26
Upside: +41.45%
Edwards Lifesciences
Dec 16, 2025
Maintains: Neutral
Price Target: $88 → $87
Current: $82.10
Upside: +5.97%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87 → $99
Current: $64.86
Upside: +52.64%
Medtronic
Nov 19, 2025
Maintains: Neutral
Price Target: $103 → $109
Current: $103.18
Upside: +5.64%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63 → $70
Current: $65.93
Upside: +6.17%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $123 → $128
Current: $91.62
Upside: +39.71%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $80.49
Upside: +36.66%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $478.88
Upside: +20.07%